Saturday, June 20, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 420 of 1,261
  1. US 10669516

    Methods and apparatus for conditioning cell populations for cell therapies

    The Board of Regents of the University of Texas System · Granted Jun 2, 2020 · Expires May 28, 2040

    granted
  2. US 10669339

    Anti-PDL1 antibodies, activatable anti-PDL1 antibodies, and methods of use thereof

    CytomX Therapeutics, Inc. · Granted Jun 2, 2020 · Expires May 28, 2040

    granted
  3. US 10669337

    Bispecific anti-CD3 antibodies, bispecific activatable anti-CD3 antibodies, and methods of using the same

    CytomX Therapeutics, Inc. · Granted Jun 2, 2020 · Expires May 28, 2040

    granted
  4. US 10669312

    Peptide for suppressing osteoclast differentiation and use thereof

    CAREGEN CO., LTD. · Granted Jun 2, 2020 · Expires May 28, 2040

    granted
  5. US 10669311

    Targeted delivery system and methods of use therefor

    SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · Granted Jun 2, 2020 · Expires May 28, 2040

    granted
  6. US 10669320

    Mps1 and KNL1 phosphorylation system

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jun 2, 2020 · Expires May 28, 2040

    granted
  7. US 10669303

    Compositions and methods directed to treating liver fibrosis

    Alnylam Pharmaceuticals, Inc. · Granted Jun 2, 2020 · Expires May 28, 2040

    granted
  8. US 10669242

    Clostridium difficile toxin inhibitors

    VENENUM BIODESIGN, LLC · Granted Jun 2, 2020 · Expires May 28, 2040

    granted
  9. US 10668170

    Modified RNAi agents

    Alnylam Pharmaceuticals, Inc. · Granted Jun 2, 2020 · Expires May 28, 2040

    granted
  10. US 10668161

    Therapeutic hyperbranched polyglycerol encapsulated biomolecules

    The Regents of the University of California · Granted Jun 2, 2020 · Expires May 28, 2040

    granted
  11. US 10668279

    Miniminally invasive dermal electroporation device

    Inovio Pharmaceuticals, Inc. · Granted Jun 2, 2020 · Expires May 28, 2040

    granted
  12. US 10668260

    Microneedle patch

    Takeda Pharmaceutical Company Limited · Granted Jun 2, 2020 · Expires May 28, 2040

    granted
  13. US 10668171

    Methods for modulating RNA splicing

    PTC THERAPEUTICS, INC. · Granted Jun 2, 2020 · Expires May 28, 2040

    granted
  14. US 10668127

    Method and composition for synchronizing time of insemination

    United-AH II, LLC · Granted Jun 2, 2020 · Expires May 28, 2040

    granted
  15. US 10668118

    Microbial consortium and uses thereof

    The Regents of the University of California · Granted Jun 2, 2020 · Expires May 28, 2040

    granted
  16. US 10668114

    Use of gram negative species to treat atopic dermatitis

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 2, 2020 · Expires May 28, 2040

    granted
  17. US 10668087

    Methods for inhibiting muscle atrophy

    United States Government as represented by the Department of Veterans Affairs · Granted Jun 2, 2020 · Expires May 28, 2040

    granted
  18. US 10668085

    Thermo-kinetic mixing for pharmaceutical applications

    The Board of Regents of the University of Texas System · Granted Jun 2, 2020 · Expires May 28, 2040

    granted
  19. US 10668062

    Oxabicycloheptanes and oxabicycloheptenes for the treatment of diabetes

    Lixte Biotechnology, Inc. · Granted Jun 2, 2020 · Expires May 28, 2040

    granted
  20. US 10668055

    Cancer treatment using combinations of ERK and RAF inhibitors

    Biomed Valley Discoveries, Inc. · Granted Jun 2, 2020 · Expires May 28, 2040

    granted
  21. US 10668082

    Vaginal inserted estradiol pharmaceutical compositions and methods

    Compass Therapeutics LLC · Granted Jun 2, 2020 · Expires May 28, 2040

    granted
  22. US 10668050

    Compositions, methods and kits for treating diarrhea-predominant irritable bowel syndrome

    RedHill Biopharma Ltd. · Granted Jun 2, 2020 · Expires May 28, 2040

    granted
  23. US 10668060

    Tamper-resistant pharmaceutical compositions of opioids and other drugs

    Collegium Pharmaceutical, Inc. · Granted Jun 2, 2020 · Expires May 28, 2040

    granted
  24. US 10668002

    Anhydrous polysaccharide films

    ReGenesis Group · Granted Jun 2, 2020 · Expires May 28, 2040

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.